Lipid Insights

S6E7: Next-Gen Lipid-Lowering Strategies: ANGPTL4 Inhibitor Clinical Insights

In this episode, Alan Brown, MD, MHA, MNLA sits down with Rebecca Juliano, PhD, MPhil, MA to discuss a first-in-human study of an investigational ANGPTL4 inhibitory antibody. The conversation explores how this novel therapeutic approach safely and effectively reduces plasma triglycerides and remnant cholesterol —key drivers of residual cardiovascular risk. Listeners will gain insight into the mechanism of action, clinical significance, and potential role of ANGPTL4 inhibition in the evolving lan...

S6E6: All Hands on Deck: The Power of Multidisciplinary Lipid Care

Explore the NLA’s new guidance on building effective, team-based approaches to improve outcomes in clinical lipidology and cardiometabolic care. Read the Expert Clinical Review HERE View this Episode on YouTube HERE Guest Host Daniel E. Soffer, MD, MNLA University of Pennsylvania Health System Internal Medicine/Clinical Lipidology Perelman Center for Advanced Medicine Philadelphia, PA Guests Mary Katherine Cheeley, PharmD, CLS, FNLA Executive Director, Ambulatory Pharmacy Services Grady Health S...

S6E5: Recognition and Management of Persistent Chylomicronemia

Dive into the complexities of Persistent Chylomicronemia with this special episode recorded live at the recent National Lipid Association Scientific Sessions. Guest host Christie Ballantyne, MD, is joined by leading experts Seyedmohammad Saadatagah, MD, Erin Michos, MD, and Daniel Gaudet, MD, PhD, to break down key takeaways from the newly released Joint Expert Clinical Consensus from the National Lipid Association and the American Society for Preventive Cardiology: Recognition and Management of...

S6E4: Familial Chylomicronemia Syndrome An Expert Clinical Review from the National Lipid Association

S6E3: Diets and Supplements

S6E2: From Research to Reality: Advancing FCS Therapy

S6E1: The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases

S5E5: Managing Hypercholesterolemia in Adults Aged 75 Years & Older w/o a History of ASCVD: A Scientific Statement from the NLA & AGS

S5E4: Role of apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults

S5E3: What’s next for Lipoprotein(a)? Insights from an Expert Discussion Group

S5E2: Palisade Phase 3 Data

Alan Brown, MD, FNLA talks with Robert Hegele, MD, FRCPC about the Arrowhead Pharma and their data on Palisade Phase 3.

S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice

Alan Brown, MD, FNLA talks with Christie Ballantyne, MD, FNLA about the publication of "A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice"

S4E2: Nutrition Interventions for Adults with Dyslipidemia

Alan Brown, MD, FNLA talks with Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA and Kevin C Maki, PhD, CLS, FNLA, FTOS, FACN to discuss Nutrition Interventions for Adults with Dyslipidemia.

S4E1: The importance of low-density lipoprotein cholesterol measurement and control as performance measures

S3E2: Statin Underuse Persistence

Alan Brown, MD, FNLA talks with Mary Katherine Cheeley, PharmD, FNLA about the persistence of statin underuse i practice.

S3E1: Tables Turned

This episodes turns the tables as NLA's own Dan Soffer pitches the questions to Lipid Insights regular host Alan Brown.

S2E6: Women's Cardiovascular Health

Dr. Alan Brown sits down with Zareen Farukhi, MD, MPH, Associate Physician at Brigham and Women's Hospital and Instructor at Harvard; and Rachel M. Bond, MD, FACC, System Director for Women's Health at Dignity Health and Assistant Professor of Medicine at Creighton University. Today, the discuss important topics in Women's Cardiovascular Health.

S2E5: Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors

Dr. Alan Brown sits down with Kim Birtcher, PharmD, Adjunct Clinical Professor at the University of Houston College of Pharmacy to discuss approaches to cardiovascular risk reduction in the age of modern therapies such as PCSK9 inhibitors.

S2E4: Genetic Variations in Patients with Very High LDL Cholesterol Including Familial Hypercholesterolemia

Dr. Alan Brown sits down with the 2020 Donald Hunninghake, MD, Familial Hypercholesterolemia (FH) Abstract Award winner to discuss genetic variations in patients with very high LDL cholesterol including familial hypercholesterolemia.

S2E3: Evinacumab: A new therapeutic option to treat dyslipidemia

Join Dr. Alan Brown and Dr. Robert Rosenson as they discuss evinacumab, a new therapeutic option for treating dyslipidemia.

S2E2: CAC Scoring: A Discussion on the Recent NLA Scientific Statement

Dr. Alan Brown sits down with Dr. Carl Orringer and Dr. Michael Blaha to take a deeper look at the recent NLA scientific statement on CAC Scoring.

S2E1: Omega 3 Outcome Trials in Perspective Part 2

Join Dr. Alan Brown as he sits down with Dr. Deepak Bhatt and Dr. Christie Ballantyne to discuss the outcomes of recent omega 3 trials and the controversies that surround them.

S2E1: Omega 3 Outcome Trials in Perspective Part 1

Join Dr. Alan Brown as he sits down with Dr. Deepak Bhatt and Dr. Christie Ballantyne to discuss the outcomes of recent omega 3 trials and the controversies that surround them.

S1E4: Special Edition: New Lipid Therapies

Dr. Alan Brown sat down with Dr. Christie Ballantyne and Dr. Scott Wright to gain insight on two new lipid therapies during NLA's LipidPALOOZA.

S1E3: Genetic Testing in Dyslipidemia

Dr. Alan Brown sits down with Dr. Rob Hegele to gain insights on the complexities of genetic testing in dyslipidemia.

S1E2: General Gaps in FH Care

Dr. Alan Browns sits down with Dr. David Davidson to provide insight into the gaps in treatment of patients with Familial Hypercholesterolemia.

S1E1: Clinical Pearls on Provider Methods for Obtaining Prior Authorizations for PCSK9i

Join Dr. Alan Brown and Dr. Kim Birtcher as they discuss the complexities of prior authorizations and what methods providers can utilize to obtain prior authorization for PCSK9i. Click here for additional materials.